Plant research has been intensified worldwide in the recent times. A large number of medicinal plants and their purified constituents have immense therapeutic potentials and have been reported to exhibit antidiabetic activity of ethanolic extract Andrographis paniculata. In vitro anti-diabetic was investigated by using alpha amylase, alpha glucosidase, tyrosinase, glucose uptake in yeast cells, heamoglobin glycosylation, extracts on heamoglobin glycosylation, extracts at physiological glucose concentration. The preliminary phytochemical analysis is also carried out. The results of the present study clearly depicted that ethanolic extract of Andrographis paniculata has potent antidiabetic activity. KEYWORDS: α-amylase, α-glucosidase, glucose uptake in yeast cells, glycated heamoglobin, tyrosinase. covers a wide range of heterogenous diseases (Bastaki, 2005). The classification and diagnostic criterion of diabetes was first put forward by the WHO in 1965.
INTRODUCTION
Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action or both. Insulin deficiency in turn leads to chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism. As the disease progresses tissue or vascular damage ensues leading to severe diabetic complications such as retinopathy, nephropathy, cardiovascular complications and microbial complications. Thus, diabetes
COMPLICATIONS OF DIABETES MELLITUS
Diabetes mellitus is a chronic condition that can lead to complications over a period of time (Fowler, 2008) . These complications include.
 Nephropathy (disease of the kidney), which can lead to kidney failure and the need for dialysis.
 Retinopathy (disease of the eye), which can lead to blindness.
 Neuropathy (disease of the nerves), which can lead to, among other things, ulceration of the foot requiring amputation.
 Coronary heart disease, which can lead to heart attack.
 Cerebrovascular disease, which can lead to strok.
 Microbial complications.
TREATMENT OF DIABETES MELLITUS
The main goals of the treatment of hyperglycemia are: 1) Alleviating symptoms, 2)
Minimizing acute complications, 3) Increasing the sense of well being and quality of life and 4) Eliminating or minimizing chronic complications. Current therapeutic agents available for type 2 diabetes include sulfonyl ureas and relatedcompounds, biguanides, α-glucosidase inhibitors and thiazolidinediones. A rational approach would be to begin with the agents particularly suited to the stage and nature of the disease, progressing, if necessary, to combination therapy. The treatment of type 1 diabetes includes the use of exogenous insulin.
USE OF MEDICINAL PLANTS FOR THE TREATMENT OF DIABETES

MELLITUS
Management of diabetes without any side effects is still a challenge in the medical field, as presently available drugs for diabetes have one or more adverse effects (Bohannon, 2002) .
Since the existing drugs for the treatment of DM do not satisfy our need completely, the search for new drugs continues. In recent years, herbal remedies for the unsolved medical problems have been gaining importance in the research field. Apart from the currently available therapeutic options, many herbal medicines have been recommended for the treatment of diabetes. Herbal drugs are prescribed widely because of their effectiveness, less side effects and relatively low cost (Venkatesh et al., 2003; Devaki et al., 2011) .
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MATERIALS AND METHODS
The fresh plant leaves was collected from Madukkur, Pattukkottai,Thanjavur district. The fresh leaves were shade dried and the leaves were powdered and sieved and used for the analysis of preliminary phytochemical analysis, in vitro anti diabetic activities.
Preliminary phytochemical screening
Qualitative phytochemical examinations were carried out of all the extract as per the standard methods.
ENZYME INHIBITORY ASSAYS OF PLANT FRACTIONS
Determination of α-amylase inhibitory activity
The assay mixture containing 200 μl of 0.02M sodium phosphate buffer, 20 μl of alpha amylase enzyme and the plant fractions (20-100 μg/ml) were incubated for 10 minutes at room temperature followed by addition of 200 μl of starch. The reaction was terminated with the addition of 400 μl DNS reagent and placed in boiling water bath for 5 minutes, cooled and diluted with 15 ml of distilled water and absorbance was measured at 540 nm.
The control samples were prepared without any plant fractions. The % inhibition was calculated as follows.
Absorbance 540 (control) -Absorbance 540 (extract) Inhibition (%) =
x 100 Absorbance 540 (control)
Metformin was used as the reference alpha amylase inhibitor. All tests were performed in triplicate. Metformin was used as the reference alpha glucosidase inhibitor. All tests were performed in triplicate.
DETERMINATION OF α -GLUCOSIDASE INHIBITORY ACTIVITY
DETERMINATION OF TYROSINASE INHIBITORY ACTIVITY
Test reaction mixtures were prepared by adding 10 μl tyrosinase to10 μl plant fractions and then adding 20 μl 1.5 mm L-tyrosine and 110 μl of 0.1 M sodium phosphate buffer (pH 6.5).
The resulting mixture (150 μl) was incubated for 10 minutes at 37°C and absorption at 490 nm was measured. The percent inhibition of tyrosinase activity was calculated as follows.
Absorbance 490 (control) -Absorbance 490 (extract)
Inhibition % =
x 100 Absorbance 490 (control)
Metformin was used as the reference tyrosinase inhibitor. All tests were performed in triplicate.
EVALUATION OF HAEMOGLOBIN GLYCOSYLATION: (CIRILLO, 1962)
GLUCOSE UPTAKE IN YEAST CELLS
The commercial baker's yeast was washed by repeated centrifugation (3,000×g; 5 minutes) in double distilled water until the supernatant fluids were clear and a 10% (v/v) suspension was prepared in distilled water. Various concentrations of JFF, BFF and PFF (50 -2000 μg/ml) were added to 1mL of glucose solution (5, 10 and 25 mm) and incubated together for 10 minutes at 37 °C. Reaction was started by adding 100 μl of yeast suspension, vortex and further incubated at 37 °C for 60 minutes.
The tubes were then centrifuged (2,500 × g, 5 minutes) and amount of glucose was estimated in the supernatant was estimated by DNS method.
The percent increase in glucose uptake by yeast cells was calculated using the following formula. 
Absorbance (sample) -Absorbance (control)
EVALUATION OF NON-ENZYMATIC GLYCOSYLATION OF HAEMOGLOBIN
PREPARATION OF HAEMOGLOBIN
The blood was collected from a healthy human volunteer and transferred into a blood bottle 
RESULTS AND DISCUSSION
Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin (a hormone that regulates blood sugar) or alternatively, when the body cannot effectively use the insulin it produces. The overall risk of dying among people with diabetes is at least double the he risk of their peers without diabetes. Diabetes and its complications impose significant economic consequences on individuals, families, health systems and countries. In this regard, our present study is concentrated on antidiabetic activity.
The following anti-diabetic parameters which are investigated in the current project are enclosed herewith. The concentration of 100µg/ml shows the maximum Tyrosinase of anti-diabetic activity of the plant extract where as 60µg/ml shows the maximum activity in the standard prescribed drug.
Glucose uptake in yeast cell
In the glucose uptake in yeast cells method the mechanism of glucose transport across the yeast cell membrane has been receiving attention as in vitro screeing method for hypoglycaemic effect of various compounds/ medicinal plants. Recent studies on the transport of on metabolizable sugars and certain metabolizable glycosides suggest that sugars transport across the yeast cell membrane is mediated by stereospecific membrane carries. It is reported that in yeast cells (Saccharomyces cerevisiae) glucose transport is transported in yeast is by a facilitated diffusion process. Facilitated carries are specific carries that transport solutes down the concentration gradient. This means that effective transport is only attained if there is removal of intracellular glucose. The concentration of 100µg/ml shows the maximum Glycated heamoglobin of anti-diabetic activity of the plant extract 60µg/ml shows the maximum activity in the standard prescribed drug.
Heamoglobin glycosylation
In diabetes mellitus, higher amounts of glycated haemoglobin, indicating poorer control of blood glucose levels, have been associated with cardiovascular disease, nephropathy, and retinopathy. A trial on a group of patients with Type 1 diabetes found that monitoring by caregivers of HbA 1C led to changes in diabetes treatment and improvement of metabolic control compared to monitoring only of blood or urine glucose.
The concentration of 100µg/ml shows the maximum Glucose uptake by yeast cells of antidiabetic activity of the plant extract 60µg/ml shows the maximum activity in the standard prescribed drug.
SUMMARY AND CONCLUSION
Herbs are staging a comeback and herbal 'renaissance' is happening all over the globe. The In this regard the effect of medicinal plants on diabetes are selected for the present study. In this study, we came to know that the parameters such as α-amylase, β-glucosidase, tyrosinase, glucose uptake by yeast cells, glycosylated haemoglobin were analysed. In our present study, all the parameters on treatment with plant exhibits more restoration of all the above said parameters into normal level than compared to the standard drugs prescribed by the physicians.
